Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines
4-triazol-4-yl)pyridine
Molecular Weight: 375
LLY-507 serves as a valuable chemical probe to aid in the dissection of SMYD2 function in cancer and other biological processes
X-ray crystallography also demonstrated that UNC2170 binds at the interface of two tudor domains of a 53BP1 dimer
BAY-57-1293 - CAS# 348086-71-5 size:10mg solid Optimization of cellular activity ofBAY 57 1293, CAS No. 348086 71 5, is a potent helicase primase inhibitor. BAY 57 1293 inhibits replication of herpes simplex virus (HSV) type 1 and type 2 in the nanomolar range in vitro by abrogating the enzymatic activity of the viral primase helicase complex. In various rodent models of HSV infection the antiviral activity of BAY 57 1293 in vivo was found to be superior compared to all compounds currently used to treat HSV infections. The compound
US$ 39.95
US$ 199.50
US$ 299.50
US$ 2295.00
US$ 699.50
US$ 34.95
US$ 99.99
US$ 39.00